#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obliterative bronchiolitis Rett syndrome Non-Hodgkin's lymphoma refractory Glomerulonephritis membranoproliferative Arterial tortuosity syndrome Epilepsy with myoclonic-atonic seizures Primitive neuroectodermal tumour Hyperinsulinaemic hypoglycaemia Enteritis Fusarium infection Red blood cell abnormality Primary immunodeficiency syndrome Neurotrophic keratopathy Dupuytren's contracture Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Diagnostics Myelodysplastic syndrome – Basic Information Wolfram syndrome – Basic Information Brain stem glioma – Treatment Noonan syndrome – Life with Disease CADASIL – Trials in Disease Wiskott-Aldrich syndrome – Trials in Disease Primary biliary cholangitis – Diagnostics Combined immunodeficiency – Basic Information Amyotrophic lateral sclerosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Maridebart Cafraglutide Indacaterol Maleate Binimetinib Peboctocogene Camaparvovec Lorazepam Itepekimab Zinc Acexamate Cpft Trifluoroacetate Fluasterone Rp1 Aldesleukin Ads-010 F44/10 Lysine Acetate Varnimcabtagene Autoleucel CARBOMER 980 Venlafaxine Ondansetron Hydrochloride Anhydrous Azithromycin Sodium Butyrate More therapies…

    Learn about Your Condition

    Acoustic neuroma Epicondylitis Intestinal ischaemia Subdural haematoma Squamous cell carcinoma Myofascial pain syndrome Mixed dementia Cardiac arrest Colitis ulcerative Dilated cardiomyopathy Prodromal Alzheimer's disease Head and neck cancer stage III Stem cell transplant Pulmonary tuberculosis Pathogen resistance More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of varegacestat (AL102) in patients with progressing desmoid tumors

    Not recruiting

    4 1
    Investigated Drugs:
    • Varegacestat
    Belgium Germany Italy The Netherlands Poland Spain

  • Study on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Bi 3032950
    Belgium Czechia Poland Slovakia

  • Study on Ulcerative Colitis: Effects of Filgotinib and Gallium (68Ga) Chloride in Patients with Intestinal Fibrosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    The Netherlands

  • Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Atezolizumab
    • Lenvatinib
    Austria Belgium Bulgaria Croatia Estonia Finland +6

  • Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Antisynthetase syndrome
    • Dermatomyositis
    • Idiopathic inflammatory myopathy
    Investigated Drugs:
    • Daxdilimab
    • Prednisone
    Czechia France Germany Italy Spain

  • Durvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma
    Investigated Drugs:
    • Vinorelbine
    • Durvalumab
    • Gemcitabine Hydrochloride
    Italy
Previous Page
1 … 912 913 914 915 916 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!